Significance of the percentage of prostate needle biopsy cores with cancer as a predictor of disease extension in radical prostatectomy specimens in Japanese men

International Urology and Nephrology

Volumn 37, Issue 2, 2005, Pages 305-310

  Sakai, Iori ^a   Harada, Ken Ichi ^a   Hara, Isao ^b   Eto, Hiroshi ^a   Miyake, Hideaki ^a  

^a HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^b KOBE UNIVERSITY   (Japan)

Author keywords

Extraprostatic extension; Percent of positive biopsy core; Prostate cancer; Radical prostatectomy

Indexed keywords

ADULT; AGED; ARTICLE; CALCULATION; CANCER ADJUVANT THERAPY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEEDLE BIOPSY; OUTCOMES RESEARCH; PREDICTION; PREOPERATIVE PERIOD; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RANDOMIZATION; STANDARDIZATION; STATISTICAL SIGNIFICANCE;

AGED; BIOPSY, NEEDLE; HUMANS; JAPAN; MALE; PREDICTIVE VALUE OF TESTS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 25144508606     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-6102-5     Document Type: Article

References (26)

1. PC. Walsh 2000 Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: A structured debate J Urol 163 1802-1807 10.1097/00005392-200006000-00039 10799186
2. TS Bates DA Gillatt PM Cavanagh et al. 1997 A comparison of endorectal magnetic resonance imaging and transrectal ultrasonography in the local staging of prostate cancer with histological correlation Br J Urol 79 927-932 9202562
3. WJ Catalona DS Smith TL Ratliff et al. 1991 Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1156-1161 1707140
4. S Soh MW Kattan S Berkman et al. 1997 Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? J Urol 1997 157 2212-2218 10.1097/00005392-199706000-00054
5. GJ O'Dowd RW Veltri R Orozco et al. 1997 Update on the appropriate staging evaluation for newly diagnosed prostate cancer J Urol 158 687-698 10.1097/00005392-199709000-00003 9258062
6. RT Vollmer DW Keetch PA. Humphrey 1998 Predicting the pathology results of radical prostatectomy from preoperative information Cancer 83 1567-1580 10.1002/ (SICI)1097-0142(19981015)83:8<1567::AID-CNCR12>3.0.CO;2-E 9781951
7. AE Katz CA Olsson AJ Raffo et al. 1994 Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay Urology 43 765-769 10.1016/0090-4295(94)90132-5 7515202
8. I Hara H Miyake S Hara et al. 2001 Value of serum prostate specific antigen alpha1-antichymotrypsin complex and its density as a predictor for the extent of prostate cancer BJU Int 88 53-57 10.1046/ j.1464-410x.2001.02238.x 11446846
9. J Pannek HG Rittenhouse DW Chan et al. 1998 The use of percent free prostate specific antigen for staging clinically localized prostate cancer J Urol 159 1238-1242 10.1097/00005392-199804000-00044 9507844
10. KJ Gancarczyk H Wu DG McLeod et al. 2003 Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: The center for prostate disease research nomograms Urology 61 589-595 10.1016/ S0090-4295(02)02287-2 12639653
11. MK Buyyounouski EM Horwitz AL Hanlon et al. 2003 Positive prostate biopsy laterality and implications for staging Urology 62 298-303 10.1016/S0090-4295(03)00334-0 12893339
12. TJ Sebo BJ Bock JC Cheville et al. 2000 The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy J Urol 163 174-178 10.1097/00005392-200001000-00041 10604340
13. DJ Grossklaus CS Coffey SB Shappell et al. 2002 Percent of cancer in the biopsy set predicts pathological findings after prostatectomy J Urol 167 2032-2036 10.1097/00005392-200205000-00020 11956432
14. RW Veltri MC Miller AW Partin et al. 2001 Prediction of prostate carcinoma stage by quantitative biopsy pathology Cancer 91 2322-2328 10.1002/1097-0142(20010615)91:12<2322::AID-CNCR1264>3.0.CO;2-H 11413521
15. V Ravery C Chastang M Toublanc et al. 2000 Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer Eur Urol 37 449-455 10.1159/000020167 10765076
16. GD Grossfeld JJ Chang JM Broering et al. 2001 Under staging and under grading in a contemporary series of patients undergoing radical prostatectomy: Results from the Cancer of the Prostate Strategic Urologic Research Endeavor Database J Urol 165 851-856 10.1097/ 00005392-200103000-00028 11176485
17. AK Lee D Schultz AA Renshaw et al. 2001 Optimizing patient selection for prostate monotherapy Int J Radiat Oncol Biol Phys 49 673-677 10.1016/ S0360-3016(00)01421-8 11172948
18. ML Blute EJ Bergstralh AW Partin et al. 2000 Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer J Urol 164 1591-1595 10.1097/00005392-200011000-00030 11025711
19. H Miyake S Hara K Yamanaka 2002 Predicting the extent of prostate cancer using a combination of serum prostate specific antigen-alpha1-antichymotrypsin complex and systematic biopsy Urol Int 68 232-236 10.1159/000058441 12053023
20. H Miyake I Sakai T Ishimura et al. 2004 Significance of cancer detection in the anterior lateral horn on systematic prostate biopsy: The effect on pathological findings of radical prostatectomy specimens BJU Int 93 57-59 10.1111/j.1464-410X.2004.04555.x
21. LH Sobin CH. Wittekind 1997 TNM Classification of Malignant Tumors 5th edn. John Wiley & Sons New York 170-173
22. AL Zietman WU Shipley JJ. Coen 1994 Radical radiation therapy in the management of prostatic adnocarcinoma: The initial prostate specific antigen value as a predictor of treatment outcome J Urol 151 640-645 7508522
23. DK Bahn F Lee MH Solomon et al. 1995 Prostate cancer: Ultrasound guided percutaneous cryoablation: Work in progress Radiology 194 551-556 7529937
24. RJ Babaian A Toi K Kamoi et al. 2000 A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy J Urol 163 152-157 10.1097/00005392-200001000-00036 10604335
25. JC Presti JJ Chang V Bhargava et al. 2000 The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: Results of a prospective clinical trial J Urol 163 163-167 10.1097/ 00005392-200001000-00038 10604337
26. ML Wills J Sauvageot AW Partin et al. 1998 Ability of sextant biopsies to predict radical prostatectomy stage Urology 51 759-764 10.1016/ S0090-4295(98)00011-9 9610589